INS and diabetes mellitus: Based on the 2020 Standards of Medical Care in Diabetes from the American Diabetes Association, T1D involves autoimmune β-cell destruction, whereas T2D is characterized by progressive loss of β-cell insulin secretion frequently on the background of insulin resistance [2].